No Data
No Data
PA GOODDOCTOR: 2024 Interim Report
Ping An Health (01833) turned losses into profits in the first half of the year, CITIC Lyon bullish on F-end business recovery, maintaining a "outperform the market" rating.
Ping An Health (01833) announced its mid-term performance for 2024, with total revenue of 2.093 billion yuan (RMB); gross profit of 0.674 billion yuan; shareholder's attributable net profit of 56.648 million yuan, compared to a shareholder's attributable loss of 0.245 billion yuan in the same period of the previous year, turning the loss into profit.
Ping An Healthcare and Technology Company Limited (HKG:1833) Just Reported, And Analysts Assigned A HK$16.50 Price Target
Hong Kong stocks rebounded | Ping An Healthcare (01833) rose more than 5% after the results announcement, with the interim shareholders' net profit accounting for 56.648 million yuan, reversing the loss from the same period last year.
Ping An Healthcare (01833) rose more than 5% after its performance, as of press time, rose 5.18%, reported HKD10.96, with a turnover of HKD18.0008 million.
Hong Kong Stock Exchange Announcement | Kuaishou-W's second quarter revenue and profit continued to grow, with adjusted net profit of 4.679 billion yuan, a year-on-year increase of 73.7%.
Kuaishou-W (01024) continued to increase its revenue and profit in the second quarter. The adjusted net profit is 4.679 billion yuan, a year-on-year increase of 73.7%; Pop Mart (09992) released its interim results, with Pop Mart's revenue in the first half of the year totaling 4.56 billion yuan, a year-on-year increase of 62%...
A glance at Ping An Health (1833.HK)'s highlights in the first half of 2024.
On August 20th, Ping An Health Medical Technology Co., Ltd. (stock code 'PA Gooddoctor', 1833.HK, hereafter referred to as 'Ping An Health') released its mid-term performance report for 2024. The specific performance will be shown in a chart to help you understand.
No Data